Mark Rogge, Ph.D.
Adjunct Professor
Teaching Profile
Courses Taught
2023-2025
PHA6418 Model-Informed Drug Development
Publications
Academic Articles
2024
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone.
CPT: pharmacometrics & systems pharmacology.
[DOI] 10.1002/psp4.13225.
[PMID] 39287606.
2019
Targeting RNA: A Transformative Therapeutic Strategy.
Clinical and translational science.
12(2):98-112
[DOI] 10.1111/cts.12624.
[PMID] 30706991.
2018
A Semi-Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy.
CPT: pharmacometrics & systems pharmacology.
7(9):581-592
[DOI] 10.1002/psp4.12323.
[PMID] 30043511.
2015
Population pharmacokinetics of recombinant factor VIII Fc fusion protein.
Clinical pharmacology in drug development.
4(3):163-74
[DOI] 10.1002/cpdd.167.
[PMID] 27140796.
2012
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Journal of clinical pharmacology.
52(6):798-808
[DOI] 10.1177/0091270011407068.
[PMID] 21680782.
2011
Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects.
Journal of clinical pharmacology.
51(7):1004-14
[DOI] 10.1177/0091270010377633.
[PMID] 20926751.
2007
Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers.
European journal of clinical pharmacology.
63(7):647-56
[PMID] 17473917.
2003
Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis.
Clinical pharmacology and therapeutics.
73(4):348-65
[PMID] 12709725.
2001
Integration of pharmacokinetic and pharmacodynamic studies in the discovery, development, and review of protein therapeutic agents: a conference report.
Clinical pharmacology and therapeutics.
69(6):387-99
[PMID] 11406736.
Grants
Apr 2021
– Mar 2023
Takeda Research Agreement – Rogge Contract
Role: Co-Project Director/Principal Investigator
Funding: TAKEDA PHARM NORTH AMERICA
Contact Details
Phones:
- Business:
- (352) 273-7851
Emails:
- Business:
- mark.rogge@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100494
GAINESVILLE FL 32610